Works matching IS 03065251 AND DT 1996 AND VI 41 AND IP 2

Results: 15

A comparative study of adverse drug reactions reported through hospital and private medicine.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 166, doi. 10.1111/j.1365-2125.1996.tb00177.x

By:

LEMOZIT, J. P.;
RHODIERE, G. PETIT;
LAPEYRE-MESTRE, M.;
BAGHERI, H.;
MONTASTRUC, J. L.

Publication type:

Article

Dose dependent time course of the analgesic effect of a sustained-release preparation of tramadol on experimental phasic and tonic pain.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 115, doi. 10.1111/j.1365-2125.1996.tb00168.x

By:

THÜRAUF, N.;
FLEISCHER, W. K.;
LIEFHOLD, J.;
SCHMID, O.;
KOBAL, G.

Publication type:

Article

The dilemma of the prolonged QT interval in early drug studies.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 77, doi. 10.1111/j.1365-2125.1996.tb00163.x

By:

THOMAS, M.;
MACONOCHIE, J. G.;
FLETCHER, E.

Publication type:

Article

Effect of ranitidine hydrochloride (150 mg twice daily) on the pharmacokinetics of increasing doses of ethanol (0. 15, 0.3, 0.6 g kg-1).

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 129, doi. 10.1111/j.1365-2125.1996.tb00170.x

By:

BYE, A.;
LACEY, L. F.;
GUPTA, S.;
POWELL, J. R.

Publication type:

Article

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 141, doi. 10.1111/j.1365-2125.1996.tb00172.x

By:

SEABER, E.;
ON, N.;
PHILLIPS, S.;
CHURCHUS, R.;
POSNER, J.;
ROLAN, P.

Publication type:

Article

Increased systemic availability of loperamide after oral administration of loperamide and loperamide oxide with cotrimoxazole.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 125, doi. 10.1111/j.1365-2125.1996.tb00169.x

By:

KAMALI, F.;
HUANG, M. L.

Publication type:

Article

low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin-induced platelet shape change and does not enhance spontaneous platelet aggregation.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 163, doi. 10.1111/j.1365-2125.1996.tb00176.x

By:

JAGKOOP, I. A.;
BARRADAS, M. A.;
MIKHAILIDIS, D. P.

Publication type:

Article

Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 83, doi. 10.1111/j.1365-2125.1996.tb00164.x

By:

LEENEN, FRANS H. H.;
FOURNEY, ANNE;
NOTMAN, GAIL;
TANNER, JOANNA

Publication type:

Article

Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 160, doi. 10.1111/j.1365-2125.1996.tb00175.x

By:

WATKINS, W. M.;
MUNGAI, M.;
MUHIA, D. K.;
MBERU, E. K.;
GATHUA, S.;
WINSTANLEY, P. A.;
GILKS's, C. F.;
NUNN, P.

Publication type:

Article

Pharmacokinetics and tolerability of meloxicam after i.m. administration.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 135, doi. 10.1111/j.1365-2125.1996.tb00171.x

By:

NARJES, H.;
TÜRCK, D.;
BUSCH, U.;
HEINZEL, G.;
NEHMIZ, G.

Publication type:

Article

Reduced renal fractional excretion of lithium in cystic fibrosis.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 157, doi. 10.1111/j.1365-2125.1996.tb00174.x

By:

BRAGER, N. P. D.;
REISCH, N. R. C. C. H.;
CHAUDHURI, M.;
RABIN, H. R.

Publication type:

Article

Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 101, doi. 10.1111/j.1365-2125.1996.tb00166.x

By:

HE, GUO-WEI;
YANG, CHENG-QIN;
GATELY, HUGH;
FURNARY, ANTHONY;
SWANSON, JEFFERY;
AHMAD, AFTAB;
FLOTEN, STORM;
Wood, James;
STARR, ALBERT

Publication type:

Article

Lanreotide inhibits human jejunal secretion induced by prostaglandin El in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 109, doi. 10.1111/j.1365-2125.1996.tb00167.x

By:

SOBHANI, IRADJ;
RENÉ AKLI RAMDANI, EMMANUEL;
BAYOD, FAYSEL;
SABBAGH, LUIS C.;
THOMAS, FRANÇOIS;
MIGNON, MICHEL

Publication type:

Article

Venlafaxine oxidation in vitro is catalysed by CYP2D6.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 149, doi. 10.1111/j.1365-2125.1996.tb00173.x

By:

OTTON, S. V.;
BALL, S. E.;
CHEUNG, S. W.;
INABA, T.;
RUDOLPH, R. L.;
SELLERS, E. M.

Publication type:

Article

On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia.

Published in:

British Journal of Clinical Pharmacology, 1996, v. 41, n. 2, p. 89, doi. 10.1111/j.1365-2125.1996.tb00165.x

By:

SALETU, B.;
GRÜNBERGER, J.;
ANDERER, P.;
LINZMAYER, L.;
KÖNIG, P.

Publication type:

Article